Cargando…

Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is a malignancy that arises from the mucosal epithelium of the nasopharynx, and its prognosis is relatively favorable. The 5-year overall survival rate in patients with locally advanced NPC currently exceeds 80%, but the development of individualized diagnosis and trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiangtao, Zhu, Huijun, Gao, Feifei, Wang, Rensheng, Hu, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588829/ https://www.ncbi.nlm.nih.gov/pubmed/34778039 http://dx.doi.org/10.3389/fonc.2021.724150

Ejemplares similares

miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma
por: Jiang, Li, et al.
Publicado: (2021)

Epithelial-mesenchymal transition classification of circulating tumor cells predicts clinical outcomes in progressive nasopharyngeal carcinoma
por: Wei, Jiazhang, et al.
Publicado: (2022)

Plasma Circulating Tumor Epstein–Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal Carcinoma
por: Liu, Guo-Ying, et al.
Publicado: (2022)

Loosening Neuro-Optic Structures Dosimetric Constraints Provides High 5-Year Local Recurrence-Free Survival With Acceptable Toxicity in T4 Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy
por: Zhang, Tingting, et al.
Publicado: (2021)

Management of Nasopharyngeal Carcinoma in Elderly Patients
por: Chan, Wing Lok, et al.
Publicado: (2022)

Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma
por: Mi, Jinglin, et al.
Publicado: (2022)

Tumor-Educated Platelets as a Promising Biomarker for Blood-Based Detection of Renal Cell Carcinoma
por: Xiao, Ruotao, et al.
Publicado: (2022)

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma
por: Tong, Xinya, et al.
Publicado: (2022)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

Intestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma
por: Jiang, Haiye, et al.
Publicado: (2019)

Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma
por: Hu, Jiyi, et al.
Publicado: (2021)

Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis
por: Zhong, Guihua, et al.
Publicado: (2022)

Radiomics Analysis and Correlation With Metabolic Parameters in Nasopharyngeal Carcinoma Based on PET/MR Imaging
por: Feng, Qi, et al.
Publicado: (2020)

LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

Application of Data Science in Circulating Tumor DNA Detection: A Promising Avenue Towards Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2021)

Association of the rs2071559 (T/C) polymorphism with lymphatic metastasis in patients with nasopharyngeal carcinoma
por: Hu, Kai, et al.
Publicado: (2017)

The clinical implications of circulating microRNAs as potential biomarkers in screening oral squamous cell carcinoma
por: Gao, Huan, et al.
Publicado: (2022)

CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023)

Tumor Blood Flow Is a Predictor of Radiotherapy Response in Patients With Nasopharyngeal Carcinoma
por: Cao, Xiujuan, et al.
Publicado: (2021)

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

Failure Patterns of Recurrence and Metastasis After Intensity-Modulated Radiotherapy in Patients With Nasopharyngeal Carcinoma: Results of a Multicentric Clinical Study
por: Chen, Sixia, et al.
Publicado: (2022)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer
por: Diao, Yanjun, et al.
Publicado: (2023)

Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma
por: Zhang, Jing, et al.
Publicado: (2018)

Transcriptomic profiling revealed FZD10 as a novel biomarker for nasopharyngeal carcinoma recurrence
por: Tulalamba, Warut, et al.
Publicado: (2023)

Clinical applications of circulating tumor cells in hepatocellular carcinoma
por: Hua, Yinggang, et al.
Publicado: (2022)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
por: Wang, Sumei, et al.
Publicado: (2019)

Tumor-Educated Platelet miR-18a-3p as a Novel Liquid-Biopsy Biomarker for Early Diagnosis and Chemotherapy Efficacy Monitoring in Nasopharyngeal Carcinoma
por: Sun, Kaiyu, et al.
Publicado: (2021)

Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management
por: Zhou, Xin, et al.
Publicado: (2021)

The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment
por: Gong, Lanqi, et al.
Publicado: (2021)

Identification of a 7‐microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection
por: Zhang, Huo, et al.
Publicado: (2019)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma
por: Zhu, Fubin, et al.
Publicado: (2023)

Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zhang, Shan-Qiang, et al.
Publicado: (2022)

Prognostic Value of CT Imaging-Based Tumor Volume in Patients With Non-Surgical Esophageal Squamous Cell Carcinoma
por: Kang, Ning, et al.
Publicado: (2021)

Radiomics for Diagnosis and Radiotherapy of Nasopharyngeal Carcinoma
por: Zhang, Yu-mei, et al.
Publicado: (2022)

Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma
por: Chen, Xi, et al.
Publicado: (2020)

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma
por: Su, Ke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jordj12hscjurirfmuf4rrd4p2